Scarica l'app Stockscreener
7.19
12.70%
0.81
Precedente Chiudi:
$6.38
Aprire:
$6.75
Volume 24 ore:
84,263
Relative Volume:
4.72
Capitalizzazione di mercato:
$65.05M
Reddito:
$27.64M
Utile/perdita netta:
$-1.04M
Rapporto P/E:
-63.24
EPS:
-0.1137
Flusso di cassa netto:
$1.22M
1 W Prestazione:
+11.65%
1M Prestazione:
+10.96%
6M Prestazione:
+6.99%
1 anno Prestazione:
+45.69%
Intervallo 1D:
$6.75
$7.4986
Intervallo di 1 settimana:
$6.3348
$7.4986
Portata 52W:
$4.52
$7.60
Immucell Corp Stock (ICCC) Company Profile
Nome
Immucell Corp
Settore
Industria
Telefono
(207) 878-2770
Indirizzo
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
7.19 | 57.72M | 27.64M | -1.04M | 1.22M | -0.1137 |
VRTX
Vertex Pharmaceuticals Inc
|
446.78 | 112.92B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
767.85 | 81.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
800.50 | 48.82B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.28 | 43.66B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.42 | 34.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immucell Corp Borsa (ICCC) Ultime notizie
ImmuCell Corporation Reports 35.7% Increase in Domestic Sales for 2026 – SEC 8-K Filing Highlights - Minichart
ImmuCell reports 28% sales increase in first quarter - Investing.com
ImmuCell (ICCC) Q1 2026 sales jump 28.4% on Tri-Shield strength - Stock Titan
One calf-health product drove ImmuCell's 28.4% Q1 sales jump - Stock Titan
Published on: 2026-04-08 23:34:29 - baoquankhu1.vn
ICCC SEC FilingsImmucell 10-K, 10-Q, 8-K Forms - Stock Titan
IMMUCELL (ICCC) director Kathy V. Turner files initial insider Form 3 - Stock Titan
ICCC PE Ratio & Valuation, Is ICCC Overvalued - Intellectia AI
Volume Report: Will ImmuCell Corporation be affected by tariffs2026 Market Trends & Low Risk Entry Point Guides - baoquankhu1.vn
ImmuCell (NASDAQ: ICCC) boosts 2025 margins, shifts from Re‑Tain to core First Defense calf-health line - Stock Titan
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
ICCC Technical Analysis | Trend, Signals & Chart Patterns | IMMUCELL CORP (NASDAQ:ICCC) - chartmill.com
ImmuCell (ICCC) director exercises 25,000 options and ends with 205,700 shares - Stock Titan
ImmuCell (ICCC) CEO granted 109,500 stock options with strict profit hurdle - Stock Titan
ImmuCell Corporation Files Form 8-K with SEC Detailing Corporate Information and Press Release March 2026 - Minichart
ImmuCell appoints Kathy Turner to board of directors - Investing.com
ImmuCell (NASDAQ: ICCC) names Kathy Turner to Board as Rosgen retires - Stock Titan
Former Elanco director joins ImmuCell board in calf-health push - Stock Titan
ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges By GuruFocus - Investing.com Canada
ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q4 2025 Earnings Call Transcript - Insider Monkey
ImmuCell Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: ImmuCell’s Q4 2025 shows growth despite challenges - Investing.com
ImmuCell Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
ICCC Earnings History & Surprises | EPS & Revenue Results | IMMUCELL CORP (NASDAQ:ICCC) - ChartMill
ImmuCell Corporation Reports Improved Financial Results for 2025 with Increased Net Operating Income and Revenue Growth - Quiver Quantitative
ImmuCell (Nasdaq: ICCC) lifts 2025 EBITDA and narrows annual net loss - Stock Titan
ImmuCell Corporation (NASDAQ:ICCC) Sees Significant Growth in Short Interest - MarketBeat
ImmuCell Corporation to Announce Unaudited Financial Results for Q4 and Year-End 2025 on March 4, 2026 - Quiver Quantitative
ImmuCell (NASDAQ:ICCC) Stock Price Crosses Above 200-Day Moving Average – What’s Next? - Defense World
Does ImmuCell Corporation have a sustainable dividendJuly 2025 WrapUp & Stepwise Entry/Exit Trade Alerts - mfd.ru
Why retail investors pile into ImmuCell Corporation stockJuly 2025 Big Picture & Low Risk Investment Opportunities - mfd.ru
Will ImmuCell Corporation benefit from AI trendsBear Alert & Weekly Momentum Stock Picks - mfd.ru
ImmuCell directors to step down at 2026 annual meeting, board changes expected By Investing.com - Investing.com South Africa
ImmuCell directors to step down at 2026 annual meeting, board changes expected - Investing.com
Two ImmuCell (ICCC) directors to step down after 2026 shareholder meeting - Stock Titan
ImmuCell announces new executive employment agreements and option grants By Investing.com - Investing.com South Africa
ImmuCell announces new executive employment agreements and option grants - Investing.com
Aug Intraday: Is ImmuCell Corporation forming a bullish divergence2025 Technical Patterns & Daily Volume Surge Trade Alerts - baoquankhu1.vn
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
ImmuCell Corporation (NASDAQ:ICCC) Short Interest Update - MarketBeat
Those who invested in ImmuCell (NASDAQ:ICCC) a year ago are up 25% - Yahoo Finance
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement - Investing.com
Is ImmuCell Corporation stock resilient to inflationQuarterly Trade Summary & Precise Trade Entry Recommendations - Улправда
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense - Investing.com
Calf health company pauses one treatment to ramp a fast-growing product - Stock Titan
Macro Review: Is ImmuCell Corporation stock near bottom after declineJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - Улправда
How rising interest rates impact ImmuCell Corporation stockCPI Data & Daily Market Momentum Tracking - ulpravda.ru
Will ImmuCell Corporation stock maintain dividend yieldJuly 2025 Short Interest & Trade Opportunity Analysis Reports - ulpravda.ru
ImmuCell Corporation Announces Investor Conference Call to Discuss Strategic Shift and Q4 2025 Sales Results - Quiver Quantitative
Immucell Corp Azioni (ICCC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.57%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):